RxDoctor Payments Data

Matt Roth, MD

Family Medicine · Toledo, OHNPI 1457566101

Payments from drug & device makers

$1,603in general payments, 2019–2025

Across 103 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$636
  • Pfizer$199
  • AstraZeneca$177
  • Lilly USA, LLC$67
  • Exact Sciences$64
  • Merck$63
  • plus $397 from 13 others

What the payments were for

  • Food & beverage$1,603100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,603 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$61,617
Medicare patients
159
Services billed
1,386

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$70,970
FarxigaDapagliflozin Propanediol24$26,824
XareltoRivaroxaban25$20,368
TrulicityDulaglutide17$15,671
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$3,755
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,564
Atorvastatin Calcium226$3,178
MovantikNaloxegol Oxalate12$2,095
Rosuvastatin Calcium79$1,739
Omeprazole116$1,619
Albuterol Sulfate HfaAlbuterol Sulfate52$1,513
Levothyroxine Sodium163$1,491
Duloxetine Hcl51$1,409
Pantoprazole Sodium63$1,248
Buprenorphine14$1,225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$636$70,97058 claims
AstraZenecaFarxiga$177$26,82424 claims
Lilly USA, LLCTrulicity$67$15,67117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →